Table 2 Comparison of treatment effects and outcomes between the two groups
Variable | Pancreatic duct stent group (n = 141) | Non-pancreatic duct stent group (n = 88) | P |
|---|---|---|---|
New complications (n, %) | 18 (12.77%) | 9 (10.22%) | 0.675 |
Whole body (N, %) | 7 (4.96%) | 5 (5.68%) | |
Local (N, %) | 8 (5.76%) | 3 (3.41%) | |
Newly OF (n, %) | 3 (2.13%) | 1 (1.13%) | |
Fasting time [d, M (IQR)] | 3 (2–4)% | 5 (4–7) | 0.001 |
Length of stay [d, M (IQR)] | 5 (3–7) | 7 (5–9) | 0.001 |
Hospitalization expenses [10 thousand, M (IQR)] | 3.53 (3.06–4.25) | 3.52 (2.88–4.19) | 0.390 |
Death (N, %) | 1 (0.71%) | 1 (1.13%) | 0.622 |